Bitte verwenden Sie diesen Link, wenn Sie dieses Dokument zitieren oder verlinken wollen: https://nbn-resolving.org/urn:nbn:de:gbv:9-opus-62695
Effect of Methylene Blue Pathogen Inactivation on the Integrity of Immunoglobulin M and G
- Introduction: In the light of the ongoing SARS-CoV-2 pandemic, convalescent plasma is a treatment option for COVID-19. In contrast to usual therapeutic plasma, the therapeutic agents of convalescent plasma do not represent clotting factor activities, but immunoglobulins. Quarantine storage of convalescent plasma as a measure to reduce the risk of pathogen transmission is not feasible. Therefore, pathogen inactivation (e.g., Theraflex®-MB, Macopharma, Mouvaux, France) is an attractive option. Data on the impact of pathogen inactivation by methylene blue (MB) treatment on antibody integrity are sparse. Methods: Antigen-specific binding capacity was tested before and after MB treatment of plasma (n = 10). IgG and IgM isoagglutinin titers were tested by agglutination in increasing dilutions. Furthermore, the binding of anti-EBV and anti-tetanus toxin IgG to their specific antigens was assessed by ELISA, and IgG binding to Fc receptors was assessed by flow cytometry using THP-1 cells expressing FcRI and FcRII. Results: There was no significant difference in the isoagglutinin titers, the antigen binding capacity of anti-EBV and anti-tetanus toxin IgG, as well as the Fc receptor binding capacity before and after MB treatment of plasma. Conclusion: MB treatment of plasma does not inhibit the binding capacity of IgM and IgG to their epitopes, or the Fc receptor interaction of IgG. Based on these results, MB treatment of convalescent plasma is appropriate to reduce the risk of pathogen transmission if quarantine storage is omitted.
Author: | Johannes Raster, Kathrin Zimmermann, Jan Wesche, Konstanze Aurich, Andreas Greinacher, Kathleen Selleng |
---|---|
URN: | urn:nbn:de:gbv:9-opus-62695 |
DOI: | https://doi.org/10.1159/000514485 |
ISSN: | 1660-3796 |
ISSN: | 1660-3818 |
Pubmed Id: | https://pubmed.ncbi.nlm.nih.gov/34177418 |
Parent Title (English): | Transfusion Medicine and Hemotherapy |
Publisher: | S. Karger AG |
Place of publication: | Basel, Switzerland |
Document Type: | Article |
Language: | English |
Date of first Publication: | 2021/02/25 |
Release Date: | 2022/12/01 |
Tag: | Immunoglobulin G; Immunoglobulin M; Methylene blue; Pathogen inactivation |
GND Keyword: | - |
Volume: | 48 |
Issue: | 3 |
First Page: | 148 |
Last Page: | 153 |
Faculties: | Universitätsmedizin / Institut für Immunologie u. Transfusionsmedizin - Abteilung Immunologie |
Licence (German): | Creative Commons - Namensnennung-Nicht kommerziell |